INTRODUCTIONMetformin, a first-line treatment for type 2 diabetes mellitus (T2DM), is increasingly recognized for its potential therapeutic relevance in dermatologic oncology. Beyond its effects on glycemic control, metformin modulates several…
Read More
INTRODUCTIONObesity and metabolic syndrome, commonly known as Syndrome X, have become increasingly common health concerns.1 As reported by the Centers for Disease Control and Prevention (CDC), nearly three-quarters of American…
Read More
INTRODUCTIONDynamic lines in the context of aesthetic medicine can be defined as lines of facial expression and are typically treated with chemodenervation from injectable botulinum toxin.1 These lines are created…
Read More
INTRODUCTIONHyperpigmentation and pigmentary disorders are prevalent dermatological concerns that can significantly impact quality of life, particularly in skin of color, as variations in pigmentation are often more noticeable.1-3 Treatment options…
Read More
To the Editor,Liquid Nitrogen (LN2) is one of the most common dermatologic procedures performed by dermatologists and other physicians. Actinic keratoses (AK), seborrheic keratoses (SK), and warts are the most…
Read More
Dear Editor,Benzoyl peroxide (BPO) is a widely used agent in the treatment of acne vulgaris (AV). Recently, concerns have emerged regarding the safety of BPO products, as they have been…
Read More
To the Editor,Autoimmune blistering disorders (AIBD) are chronic, antibodymediated diseases of the skin and mucous membranes that carry substantial morbidity and mortality.1,2 Previous studies have suggested an association with malignancy,…
Read More
INTRODUCTIONThe appropriate size of surgical margins for stages after a positive Mohs micrographic surgery (MMS) stage has not been well studied. Proposed minimum peripheral margins (mPM) for excision can be…
Read More
To the Editor,Chronic kidney disease (CKD) affects approximately 14% of adults nationally and is characterized by impaired immunity, systemic inflammation, and microvascular dysfunction.1,2 These physiologic disruptions impair wound healing and…
Read More
INTRODUCTIONPatients with inflammatory alopecias face a potentially greater risk of cutaneous neoplasms in affected areas, likely due to chronic inflammation and reduced hair coverage.1 While there have been isolated reports…
Read More
INTRODUCTIONAlopecia areata (AA) is a chronic autoimmune disorder resulting in patchy, non-scarring hair loss on the face, body, and/or scalp.1 It is postulated to result from the collapse of hair…
Read More
In this issue:2025 POSTER ABSTRACTS SUPPLEMENTIt is my distinct honor to introduce this special supplement to the Journal of Drugs in Dermatology (JDD) featuring abstracts presented at the 2025 Annual…
Read More





